In vitro perfusion studies of human resistance artery function in essential hypertension

Hypertension

Volumn 24, Issue 1, 1994, Pages 16-23

  Falloon, Brendan J ^a   Heagerty, Anthony M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

acetylcholine; endothelium; hypertension, essential; nitroprusside; norepinephrine; perfusion; vascular resistance

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTICLE; BIOPSY; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; ISOLATED ARTERY; MALE; MYOGRAPHY; PERFUSION; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0028277661     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.24.1.16     Document Type: Article

References (38)

1. Lund-Johansson P. Haemodynamics in essential hypertension. Clin Sci. 1980;59:343-354.
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921-960.
3. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
4. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A. Captopril improves endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
5. Yoshida M, Imaizumi T, Ando S, Hirooka Y, Harada S, Takeshita A. Impaired forearm vasodilatation by acetylcholine in patients with hypertension. Heart Vessels. 1991;6:218-223.
6. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
7. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;2: 181-186.
8. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 1976;260:617-619.
9. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
10. Sipkema P, Westerhof N. Mechanics of a thin-walled collapsible microtube. Ann Biomed Eng. 1989;17:203-217.
11. Halpern W, Kelley M. In vitro methodology for resistance arteries. Blood Vessels. 1991;18:543-549.
12. Aalkjaer C, Pedersen EB, Danielsen H, Fjeldborg O, Jespersen B, Kjaer T, Sorensen SS, Mulvany MJ. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci. 1986;71:657-663.
13. Falloon BJ, Bund SJ, Tulip JR, Heagerty AM. In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension. 1993;22:486-495.
14. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford, England: Blackwell Scientific Publications; 1987:203.
15. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension. 1993;21:391-397.
16. Furuyama M. Histometrical investigations of arteries in reference to hypertension. Tohoku J Exp Med. 1962;76:388-414.
17. Short D. Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J. 1966;28:184-192.
18. Duff RS. Adrenaline sensitivity of peripheral blood vessels in human hypertension. Br Heart J. 1956;19:45-52.
19. Eliasson K, Hjemdahl P, Kahan T. Circulatory and sympathoadrenal responses to stress in borderline and established hypertension. J Hypertens. 1983;1:131-139.
20. Hulthen UL, Bolli P, Kiowski W, Buhler FR. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension. J Cardiovasc Pharmacol. 1984; 6(suppl 1):S75-S81.
21. Sivertsson R. The haemodynamic importance of structural vascular changes in essential hypertension. Act Physiol Scand Suppl. 1970; 343:1-56.
22. +-pump induces an enhanced vasoconstriction in borderline but not in essential hypertension. Gen Pharmacol 1983;14:193-196.
23. Moulds RFW. Reduced responses to noradrenaline of isolated digital arteries from hypertensives. Clin Exp Pharmacol Physiol. 1980;7:505-508.
24. Horwitz D, Clineschmidt BV, Vanburen JM, Ommaya AK. Temporal arteries from hypertensive and normotensive man. Circ Res. 1974;34,35(suppl I):I-109-I-115.
25. Thulesius O, Gjores JE, Berlin E. Vascular reactivity of normotensive and hypertensive human arteries. Gen Pharmacol. 1983; 14:153-154.
26. Wyse DG. Relationship of blood pressure to the responsiveness of an isolated human artery to selected agonists and to electrical stimulation. J Cardiovasc Pharmacol. 1984;6:1083-1091.
27. Angus JA, Jennings GL, Sudhir K. Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension. Clin Exp Pharmacol. 1992;19(suppl): 39-47.
28. Abboud FM. The sympathetic system in hypertension. Hypertension. 1982;4(suppl II):II-208-II-225.
29. Hano T, Rho J. Norepinephrine overflow in perfused mesenteric resistance vessels of spontaneously hypertensive rats. Hypertension. 1989;14:44-53.
30. Gordon FJ, Haywood JR, Brody MJ, Johnson AK. Effects of lesions of the anteroventral third ventricle (AV3V) on the development of hypertension in spontaneously hypertensive rats. Hypertension. 1982;4:387-393.
31. Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels. 1989;26:1-20.
32. Mulvany MJ, Aalkjaer C, Christensen J. Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension. 1980;2:664-671.
33. Kong JQ, Taylor DA, Fleming WW. Mesenteric vascular responses of young spontaneously hypertensive rats. J Pharmacol Exp Ther. 1991;258:13-17.
34. Webb RC, Vanhoutte PM. Sensitivity to noradrenaline in isolated tail arteries from spontaneously hypertensive rats. Clin Sci. 1979; 57(suppl 5):31-33.
35. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P. Noradrenaline kinetics in essential hypertension: defective neuronal uptake of norepinephrine in some patients. Hypertension. 1981;3:149-156.
36. 3H] isoproterenol kinetics in essential hypertension. J Clin Invest. 1983; 72:1748-1758.
37. Esler M, Jackman G, Leonard P, Bobik A, Skews H, Jennings G, Kelleher D, Korner P. Determination of noradrenaline uptake, spillover to plasma and plasma concentrations in patients with essential hypertension. Clin Sci. 1980;59:311-313.
38. Palmer PMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:525-526.